South Korea Prostate Cancer Therapeutics Market Size & Outlook
Related Markets
South Korea prostate cancer therapeutics market highlights
- The South Korea prostate cancer therapeutics market generated a revenue of USD 395.0 million in 2024 and is expected to reach USD 620.2 million by 2030.
- The South Korea market is expected to grow at a CAGR of 8.2% from 2025 to 2030.
- In terms of segment, hormonal therapy was the largest revenue generating drug class in 2024.
- Hormonal Therapy is the most lucrative drug class segment registering the fastest growth during the forecast period.
Prostate cancer therapeutics market data book summary
| Market revenue in 2024 | USD 395.0 million |
| Market revenue in 2030 | USD 620.2 million |
| Growth rate | 8.2% (CAGR from 2025 to 2030) |
| Largest segment | Hormonal therapy |
| Fastest growing segment | Hormonal Therapy |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, Other Drug Class |
| Key market players worldwide | Johnson & Johnson, Astellas Pharma Inc, Eli Lilly and Co, Sanofi SA, Ipsen SA, Bayer AG, AstraZeneca PLC, Bausch Health Companies Inc, Merck & Co Inc, Pfizer Inc |
Other key industry trends
- In terms of revenue, South Korea accounted for 2.3% of the global prostate cancer therapeutics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China prostate cancer therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,513.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Prostate Cancer Therapeutics Market Scope
Prostate Cancer Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Ipsen SA | View profile | 5325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | https://www.ipsen.com |
| Bausch Health Companies Inc | View profile | 20270 | 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 | https://www.bauschhealth.com |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
South Korea prostate cancer therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to prostate cancer therapeutics market will help companies and investors design strategic landscapes.
Hormonal therapy was the largest segment with a revenue share of 93.95% in 2024. Horizon Databook has segmented the South Korea prostate cancer therapeutics market based on hormonal therapy, chemotherapy, immunotherapy, targeted therapy, other drug class covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to South Korea prostate cancer therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea prostate cancer therapeutics market databook
-
Our clientele includes a mix of prostate cancer therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea prostate cancer therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea prostate cancer therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea prostate cancer therapeutics market size, by drug class, 2018-2030 (US$M)
South Korea Prostate Cancer Therapeutics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
